Fuzionaire Diagnostics

📍 The Woodlands, United States🗓 Founded 2018👥 6 employees
Pharmaceutical Manufacturing🌐 fuzionairedx.com
Website LinkedIn
Fuzionaire Diagnostics is a radiopharmaceutical company on a mission to develop accessible theranostics to fight cancer. With origins in Nobel laureate Robert Grubbs' lab at Caltech, our patented HetSiFA library can create theranostic radiopharmaceutical candidates from disease-targeting peptides and other ligands within weeks. Our platform also enables unique flexibility in the choice of the radionuclide used for imaging or therapy and offers manufacturing advantages in a clinical setting that enable the wider use of these important precision treatments. For more, visit us at: www.fuzionairedx.com
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
2018
Founded

Investors

0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
When was Fuzionaire Diagnostics founded?
Fuzionaire Diagnostics was founded in 2018.
What industry is Fuzionaire Diagnostics in?
Fuzionaire Diagnostics operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Fuzionaire Diagnostics based?
Fuzionaire Diagnostics is headquartered in The Woodlands, United States.